Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Andrei

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
International Journal of Cardiology|June 30, 2024
Resurrection of classical antiarrhythmic drugsG Andrei Dan
International Journal of Cardiology|July 28, 2017
Atrial fibrillation: Applying evidence out of the boxG Andrei Dan
Advances in Pharmacology (San Diego, Calif.)|July 27, 2013
Advances in the treatment of varicella-zoster virus infectionsG Andrei, R Snoeck
Antiviral Research|October 1, 1990
Inhibitory effect of selected antiviral compounds on arenavirus replication in vitroG Andrei, E De Clercq
Antiviral Research|September 1, 1993
Molecular approaches for the treatment of hemorrhagic fever virus infectionsG Andrei, E De Clercq
JRSM Cardiovascular Disease|May 26, 2026
The present and future of antiarrhythmic drugsSamuel Nistor, G-Andrei Dan
Antiviral Research|December 4, 2012
The large tumor antigen: a "Swiss Army knife" protein possessing the functions required for the polyomavirus life cycleD Topalis, G Andrei, R Snoeck
Virologie (Montrouge, France)|September 24, 2022
[Novel therapeutic weapons against poxviruses]S Duraffour, G Andrei, R Snoeck
Drugs|April 3, 1999
Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatmentR Snoeck, G Andrei, E De Clercq
Antimicrobial Agents and Chemotherapy|December 3, 1998
The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetilJ Neyts, G Andrei, E De Clercq
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Cardiology|June 30, 2024
Resurrection of classical antiarrhythmic drugsG Andrei Dan
International Journal of Cardiology|July 28, 2017
Atrial fibrillation: Applying evidence out of the boxG Andrei Dan
Advances in Pharmacology (San Diego, Calif.)|July 27, 2013
Advances in the treatment of varicella-zoster virus infectionsG Andrei, R Snoeck
Antiviral Research|October 1, 1990
Inhibitory effect of selected antiviral compounds on arenavirus replication in vitroG Andrei, E De Clercq
Antiviral Research|September 1, 1993
Molecular approaches for the treatment of hemorrhagic fever virus infectionsG Andrei, E De Clercq
JRSM Cardiovascular Disease|May 26, 2026
The present and future of antiarrhythmic drugsSamuel Nistor, G-Andrei Dan
Antiviral Research|December 4, 2012
The large tumor antigen: a "Swiss Army knife" protein possessing the functions required for the polyomavirus life cycleD Topalis, G Andrei, R Snoeck
Virologie (Montrouge, France)|September 24, 2022
[Novel therapeutic weapons against poxviruses]S Duraffour, G Andrei, R Snoeck
Drugs|April 3, 1999
Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatmentR Snoeck, G Andrei, E De Clercq
Antimicrobial Agents and Chemotherapy|December 3, 1998
The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetilJ Neyts, G Andrei, E De Clercq
Pageof 15